✉news BusinessRetail first seen 8 d ago, last 1 d ago, peak #6

ImmunityBio Shares Post Best Week In Over Seven Months

Original: IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump’s Cancer Panel Pick

ImmunityBio stock (IBRX) recorded its strongest weekly performance in more than seven months, drawing attention from retail investors. Traders are speculating that Anktiva, the company's bladder cancer drug, could get a lift following Donald Trump's choice for his cancer panel, fueling optimism about regulatory and commercial support for the therapy.

Why now: Retail investors are betting Trump's cancer panel pick could boost sales prospects for ImmunityBio's drug Anktiva.

ImmunityBioAnktivaDonald Trump

Open on news →

Evidence

• IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump’s Cancer Panel Pick · Stocktwits
• IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump’s Cancer Panel Pick · TradingView

API: https://socialmediatrends-api.osmike.com/v1/trends/1057495